Business Description
AbCellera Biologics Inc
NAICS : 541714
SIC : 3741
ISIN : CA00288U1066
Description
Financial Strength
6/10
Name | Current | Vs Industry | Vs History | |||
---|---|---|---|---|---|---|
Cash-To-Debt | 9.48 | |||||
Equity-to-Asset | 0.77 | |||||
Debt-to-Equity | 0.07 | |||||
Debt-to-EBITDA | -0.4 | |||||
Interest Coverage | N/A | |||||
Piotroski F-Score | 3/9 | |||||
Altman Z-Score | 2.59 | |||||
Beneish M-Score | -2.04 | |||||
WACC vs ROIC |
Growth Rank
2/10
Name | Current | Vs Industry | Vs History | |||
---|---|---|---|---|---|---|
3-Year Revenue Growth Rate | -47.1 | |||||
3-Year Book Growth Rate | 8.7 | |||||
Future 3-5Y Total Revenue Growth Rate | 14.05 |
Momentum Rank
2/10
Name | Current | Vs Industry | Vs History | |||
---|---|---|---|---|---|---|
5-Day RSI | 74.08 | |||||
9-Day RSI | 63.25 | |||||
14-Day RSI | 56.01 | |||||
6-1 Month Momentum % | -15.27 | |||||
12-1 Month Momentum % | -45.31 |
Liquidity Ratio
Name | Current | Vs Industry | Vs History | |||
---|---|---|---|---|---|---|
Current Ratio | 7.76 | |||||
Quick Ratio | 7.75 | |||||
Cash Ratio | 6.66 | |||||
Days Sales Outstanding | 342.96 |
Dividend & Buy Back
Name | Current | Vs Industry | Vs History | |||
---|---|---|---|---|---|---|
3-Year Average Share Buyback Ratio | -2.6 | |||||
Shareholder Yield % | -0.79 |
Profitability Rank
7/10
Name | Current | Vs Industry | Vs History | |||
---|---|---|---|---|---|---|
Operating Margin % | -595.65 | |||||
Net Margin % | -410.47 | |||||
FCF Margin % | -357.77 | |||||
ROE % | -12.52 | |||||
ROA % | -9.8 | |||||
ROIC % | -28.5 | |||||
ROC (Joel Greenblatt) % | -78.15 | |||||
ROCE % | -15.32 | |||||
Years of Profitability over Past 10-Year | 4 |
GF Value Rank
1/10
Name | Current | Vs Industry | Vs History | |||
---|---|---|---|---|---|---|
PS Ratio | 32.58 | |||||
PB Ratio | 1.05 | |||||
Price-to-Tangible-Book | 1.22 | |||||
EV-to-EBIT | -2.64 | |||||
EV-to-Forward-EBIT | -1.71 | |||||
EV-to-EBITDA | -3.09 | |||||
EV-to-Forward-EBITDA | -1.93 | |||||
EV-to-Revenue | 15.75 | |||||
EV-to-Forward-Revenue | 8.29 | |||||
EV-to-FCF | -4.4 | |||||
Price-to-Net-Current-Asset-Value | 2.44 | |||||
Price-to-Net-Cash | 3.23 | |||||
Earnings Yield (Greenblatt) % | -37.88 | |||||
FCF Yield % | -10.79 |
Historical Operating Revenue by Business Segment
Historical Operating Revenue by Geographic Region
Guru Trades
See DetailsInsider Trades
See DetailsPeter Lynch Chart
Performance
Annualized Return % Â
Total Annual Return % Â
AbCellera Biologics Inc Executives
DetailsAnalyst Estimate
Key Statistics
Name | Value | ||
---|---|---|---|
Revenue (TTM) (Mil €) | 33.04 | ||
EPS (TTM) (€) | -0.481 | ||
Beta | 0.89 | ||
Volatility % | 52.67 | ||
14-Day RSI | 56.01 | ||
14-Day ATR (€) | 0.108817 | ||
20-Day SMA (€) | 3.5951 | ||
12-1 Month Momentum % | -45.31 | ||
52-Week Range (€) | 3.325 - 7.2 | ||
Shares Outstanding (Mil) | 294.05 |
Piotroski F-Score Details
Component | Result | ||
---|---|---|---|
Piotroski F-Score | 3 | ||
Positive ROA | |||
Positive CFROA | |||
Higher ROA yoy | |||
CFROA > ROA | |||
Lower Leverage yoy | |||
Higher Current Ratio yoy | |||
Less Shares Outstanding yoy | |||
Higher Gross Margin yoy | |||
Higher Asset Turnover yoy |
AbCellera Biologics Inc Filings
Filing Date | Document Date | Form | ||
---|---|---|---|---|
No Filing Data |
AbCellera Biologics Inc Stock Events
Event | Date | Price(€) | ||
---|---|---|---|---|
No Event Data |
AbCellera Biologics Inc Frequently Asked Questions
What is AbCellera Biologics Inc(FRA:8QQ)'s stock price today?
When is next earnings date of AbCellera Biologics Inc(FRA:8QQ)?
Does AbCellera Biologics Inc(FRA:8QQ) pay dividends? If so, how much?
Press Release
Subject | Date | |||
---|---|---|---|---|
No Press Release |